Asymchem's Dunhua 2 Carbapenem Manufacturing Site Successfully Completes its First FDA Inspection for Continuous Manufacturing of an API

TIANJIN, China, July 24, 2026 /PRNewswire/ -- Asymchem, a leading global contract development and manufacturing organization (CDMO), announced that its dedicated carbapenem API manufacturing facility (Jilin Asymchem Pharmaceuticals Co. Ltd., also known as "DH2") successfully completed its...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.